{"id":"https://openalex.org/W7225150911","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0921","title":"921 Hybrid lipid nanoparticles enable in situ and ex vivo dendritic cell-based cancer immunotherapy","display_name":"921 Hybrid lipid nanoparticles enable in situ and ex vivo dendritic cell-based cancer immunotherapy","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225150911","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0921"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0921","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0921","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0921","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1044.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A1044.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109296482","display_name":"Riddha Das","orcid":"https://orcid.org/0000-0001-9258-5488","observed_orcids":["https://orcid.org/0000-0001-9258-5488"]},"institutions":[{"id":"https://openalex.org/I44461941","display_name":"University of Houston","ror":"https://ror.org/048sx0r50","country_code":"US","type":"education","lineage":["https://openalex.org/I44461941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Riddha Das","raw_affiliation_strings":["University of Houston, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Houston, Houston, TX, USA","institution_ids":["https://openalex.org/I44461941"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090885075","display_name":"Christopher Garris","orcid":"https://orcid.org/0000-0002-5764-6203","observed_orcids":["https://orcid.org/0000-0002-5764-6203"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher S Garris","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067255019","display_name":"Ralph Weissleder","orcid":"https://orcid.org/0000-0003-0828-4143","observed_orcids":["https://orcid.org/0000-0003-0828-4143"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph Weissleder","raw_affiliation_strings":["Harvard Medical School, Boston, MA, USA","Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1044","last_page":"A1044"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dendritic-cell-based-cancer-immunotherapy","display_name":"dendritic cell-based cancer immunotherapy","score":0.8629999756813049},{"id":"https://openalex.org/keywords/poly-i-c","display_name":"poly(I:C)","score":0.6660000085830688},{"id":"https://openalex.org/keywords/cyclodextrin-nanoparticles","display_name":"cyclodextrin nanoparticles","score":0.9309999942779541},{"id":"https://openalex.org/keywords/non-canonical-nf-kappab-signaling","display_name":"non-canonical NF-\u03baB signaling","score":0.9539999961853027},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.8209999799728394},{"id":"https://openalex.org/keywords/mrna-lnp","display_name":"mRNA-LNP","score":0.42899999022483826},{"id":"https://openalex.org/keywords/antigen-delivery","display_name":"antigen delivery","score":0.6579999923706055},{"id":"https://openalex.org/keywords/adoptive-cell-transfer","display_name":"adoptive cell transfer","score":0.574999988079071},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.4180000126361847},{"id":"https://openalex.org/keywords/cd8-t-cell-infiltration","display_name":"CD8+ T cell infiltration","score":0.7710000276565552},{"id":"https://openalex.org/keywords/intratumoral-delivery","display_name":"intratumoral drug delivery","score":0.48899999260902405},{"id":"https://openalex.org/keywords/mc38-tumor-model","display_name":"MC38 tumor","score":0.5320000052452087},{"id":"https://openalex.org/keywords/b16-ova-melanoma","display_name":"B16-OVA melanoma","score":0.9340000152587891}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8507000207901001},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.7020000219345093},{"id":"https://openalex.org/C2777822432","wikidata":"https://www.wikidata.org/wiki/Q216681","display_name":"In situ","level":2,"score":0.6189000010490417},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6169999837875366},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5938000082969666},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5188999772071838},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4343000054359436},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.39239999651908875},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.37290000915527344},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.37220001220703125},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.3441999852657318},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.3366999924182892},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3001999855041504},{"id":"https://openalex.org/C3018040386","wikidata":"https://www.wikidata.org/wiki/Q189206","display_name":"Lipid vesicle","level":4,"score":0.2989000082015991},{"id":"https://openalex.org/C2992125399","wikidata":"https://www.wikidata.org/wiki/Q2824461","display_name":"Lipid accumulation","level":2,"score":0.257999986410141},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.2524000108242035}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0921","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0921","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0921","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1044.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:028990faecc645af806f4c122a81a418","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/028990faecc645af806f4c122a81a418","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss Suppl 2 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0921","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0921","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0921","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1044.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225150911.pdf","grobid_xml":"https://content.openalex.org/works/W7225150911.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2340974653","https://openalex.org/W2418180064","https://openalex.org/W4234101834","https://openalex.org/W2066214537","https://openalex.org/W1032925166","https://openalex.org/W2113298113","https://openalex.org/W2072974627","https://openalex.org/W2766490371","https://openalex.org/W2007523399","https://openalex.org/W4399515643"],"abstract_inverted_index":{"Background":[0],"Dendritic":[1,442],"cells":[2,472,485],"are":[3],"central":[4],"to":[5,26,46,53,63,112,139,345],"initiating":[6],"antitumor":[7,353],"immunity,":[8,386],"but":[9],"their":[10],"therapeutic":[11],"activation":[12,76,184],"requires":[13],"coordinated":[14,340],"stimulation":[15],"of":[16,68,86,233,249,306],"multiple":[17],"intracellular":[18],"pathways.":[19],"1":[20],"We":[21,58],"developed":[22],"complementary":[23,341,376],"LNP-based":[24],"strategies":[25,461],"engineer":[27],"DC":[28,162,329,363,409],"function":[29],"in":[30,36,129,152,377,477],"situ":[31,37,378,454,466],"and":[32,49,74,90,100,108,122,146,160,163,185,188,202,216,220,263,281,294,311,317,349,371,379,390,455,473],"ex":[33,64,177,356,380,456,481],"vivo.2":[34],"For":[35],"activation,":[38],"a":[39,230,332],"hybrid":[40,251],"\u2018nanoparticle-in-nanoparticle\u2019":[41],"LNP":[42,440],"co-delivered":[43],"poly":[44,101,213],"I:C":[45,102,214],"activate":[47,346],"TLR3":[48],"LCL-161-loaded":[50,97],"cyclodextrin":[51],"nanoparticles":[52],"stimulate":[54],"noncanonical":[55],"NF-\u03baB":[56],"signaling.":[57],"then":[59],"extended":[60],"this":[61],"approach":[62],"vivo":[65,178,299,357,381,457,482],"LNP-mRNA":[66,358],"engineering":[67,330,359,460],"DCs,":[69,307],"enabling":[70],"controlled":[71],"antigen":[72,186,309],"delivery":[73],"cellular":[75,144,369],"while":[77,355,480],"limiting":[78],"systemic":[79,171,352,372,393],"exposure":[80],"(figure":[81],"1).Methods":[82],"Hybrid":[83,338,439],"LNPs":[84,136,252,339,468],"composed":[85],"C12-200,":[87],"DSPC,":[88],"cholesterol,":[89],"DMG-PEG2000":[91],"were":[92,103,116,137,168,175,269],"generated":[93,391],"by":[94,149,257,271,322],"microfluidic":[95],"mixing.":[96],"lipophilic":[98],"CDNPs":[99],"incorporated":[104],"into":[105],"the":[106,250],"aqueous":[107],"organic":[109],"phases,":[110],"respectively":[111],"formulate":[113],"LNPs.":[114],"Formulations":[115],"characterized":[117,182],"for":[118,183,335,444,462],"size,":[119],"surface":[120],"charge,":[121],"encapsulation":[123,215],"efficacy.":[124],"Immune":[125,415],"activity":[126],"was":[127,198],"evaluated":[128,169],"IL-12-eYFP":[130],"reporter":[131],"bone":[132],"marrow-derived":[133],"DCs.":[134],"Fluorescent":[135],"used":[138],"assess":[140],"circulation,":[141],"tumor":[142,255,320,388],"accumulation,":[143],"uptake,":[145],"IL-12":[147,223,240],"induction":[148,241],"intravital":[150],"imaging":[151],"MC38":[153,254,478],"tumors.":[154],"Antitumor":[155],"efficacy,":[156],"survival,":[157],"rechallenge":[158,285],"protection,":[159],"intratumoral":[161,239],"CD8":[164],"+":[165],"T-cell":[166,296,385],"infiltration":[167],"after":[170,284],"administration.":[172],"Separately,":[173],"BMDCs":[174],"engineered":[176],"with":[179,237,365],"OVA":[180,300],"mRNA-LNPs,":[181],"presentation,":[187],"adoptively":[189],"transferred":[190],"before":[191],"B16-OVA":[192,319,489],"challenge.Results":[193],"The":[194],"optimized":[195],"LNP17":[196,228],"formulation":[197],"approximately":[199,211,234,258,304],"120":[200],"nm":[201],"contained":[203],"an":[204],"internal":[205],"CDNP":[206,218],"(~38":[207],"nm).":[208],"It":[209],"achieved":[210,474],"75%":[212,305],"18.6%":[217],"incorporation":[219],"induced":[221],"higher":[222],"levels":[224],"than":[225],"single-payload":[226],"controls.":[227],"exhibited":[229],"vascular":[231],"half-life":[232],"30":[235],"minutes,":[236],"maximal":[238],"at":[242],"72":[243],"hours.":[244,267],"A":[245],"single":[246],"intravenous":[247],"dose":[248],"reduced":[253],"volume":[256],"30%":[259],"within":[260,265],"24":[261],"hours":[262],"80%":[264],"48":[266],"Tumors":[268],"eradicated":[270],"day":[272],"18,":[273],"yielding":[274],"100%":[275],"long-term":[276],"survival":[277,476,487],"(":[278],"figure":[279],"1)":[280],"complete":[282,475],"protection":[283],"two":[286],"months":[287],"later.":[288],"Histology":[289],"showed":[290],"increased":[291],"CD11c+":[292],"DCs":[293,348],"CD8+":[295],"infiltration.":[297],"Ex":[298],"mRNA-LNP":[301],"treatment":[302],"activated":[303,469],"enhanced":[308,383],"presentation":[310],"costimulatory":[312],"markers,":[313],"stimulated":[314],"OT-I":[315],"proliferation,":[316],"delayed":[318],"appearance":[321],"one":[323],"week.Conclusions":[324],"These":[325],"studies":[326],"establish":[327],"LNP-mediated":[328],"as":[331],"versatile":[333],"strategy":[334],"cancer":[336,463],"immunotherapy.":[337,464],"innate":[342],"immune":[343,394],"pathways":[344],"endogenous":[347,470],"generate":[350],"potent":[351],"responses,":[354],"produced":[360],"activated,":[361],"antigen-presenting":[362],"vaccines":[364],"greater":[366],"control":[367],"over":[368],"programming":[370],"exposure.":[373],"Together,":[374],"these":[375],"approaches":[382],"DC-mediated":[384],"improved":[387,486],"control,":[389],"durable":[392],"memory.References":[395],"Das":[396],"R,":[397,403,420,434],"Ge":[398,429],"X,":[399,430],"Fei":[400],"F,":[401],"Weissleder":[402,437],"Garris":[404,435],"CS.":[405],"Lipid":[406],"Nanoparticle-mRNA":[407],"Engineered":[408],"Adoptive":[410],"Cell":[411],"Therapy":[412],"Enhances":[413],"Cancer":[414],"Response.":[416],"Small":[417],"Methods":[418],"2024;24\u201333.Das":[419],"Halabi":[421],"EA,":[422],"Fredrich":[423],"IR,":[424],"Oh":[425],"J,":[426],"Peterson":[427],"HM,":[428],"Scott":[431],"E,":[432],"Kohler":[433],"CS,":[436],"R.":[438],"Prime":[441],"Cells":[443],"Nucleotide":[445],"Delivery.":[446],"Adv":[447],"Sci.":[448],"2023;23\u201335.Abstract":[449],"921":[450],"Figure":[451],"1Complementary":[452],"In":[453,465],"dendritic":[458,471,484],"cell":[459],"immunostimulatory":[467],"tumors,":[479],"LNP-mRNA-engineered":[483],"following":[488],"challenge":[490]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-04T00:00:00"}